Advancing Art Through Stem Cell Science
October, 2025 - CaseBioscience is advancing ART by applying its stem cell preservation expertise to develop next-generation embryo culture and handling media, now FDA-cleared and set to debut at ASRM 2025. Supported by strong regulatory foundations—including ISO 13485:2016, MDSAP, and Health Canada approval—the company is also progressing new submissions for its clinical-grade CaseCryo® CTG and CaseStor® HSS solutions. With growing scientific recognition through accepted conference presentations, CaseBioscience continues to unite stem cell science and ART to drive innovation in reproductive medicine.
